Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GA-binding protein transcription factor subunit beta-2 (GABPB2) is a protein coding gene that encodes a subunit of the GA-binding protein (GABP) transcription factor complex. GABPB2 participates in forming a tetrameric complex with the GABPA subunit and is involved in stimulating transcription of target genes, particularly by binding to purine-rich (GA repeat) elements. It is thought to play a role in the activation of key genes in development, regulation of the cell cycle, positive regulation of transcription, and may have a role in nuclear control of mitochondrial function. GABPB2 has been linked to neurological and cancer-associated processes such as gliomagenesis and is being studied as a potential biomarker and therapeutic target in tumors, notably glioblastoma[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GA-binding protein transcription factor subunit beta-2 (GABPB2).